Should we apply?
7 questions about Forecast to Publish a Notice of Funding Opportunity for SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional). The first ones are deal-breakers: grant professionals check them before writing anything. We filled in what we know. Change anything that's wrong.